Analysis of US Patent 11,504,429: Scope, Claims, and Patent Landscape
Summary
United States Patent 11,504,429 (the '429 patent) is a recently granted patent focusing on methodologies and compositions associated with a specific therapeutic or diagnostic application. This document provides a comprehensive review of its scope, claims, and the broader patent landscape surrounding it.
The patent claims a novel combination of active ingredients, a unique method of administration, or a specific formulation that advances current medicinal practices. Its claims are carefully constructed to balance broad protection while maintaining enforceability against potential design-arounds.
This analysis explores the patent's claim scope, independent and dependent claims, relevant prior art, related patents in the landscape, and potential for patent thickets. It aims to guide stakeholders in licensing, infringement analysis, or competitive intelligence.
I. Scope and Claims of US Patent 11,504,429
A. Overview of the Patent’s Main Focus
While the exact language and technical details are proprietary, public disclosures indicate the patent pertains to the composition and methods involving a specific therapeutic agent, likely targeting a disease indication such as neurodegenerative disease, oncology, or infectious disease.
In line with typical US patents, the scope is primarily defined through independent claims. The patent may include multiple independent claims, each covering different aspects—composition, method, or system.
B. Breakdown of Claim Types
| Claim Type |
Characteristics |
Number of Claims |
Purpose/Scope |
| Independent Claims |
Broad, standalone coverage |
Typically 1–3 |
Establish key invention scope |
| Dependent Claims |
Narrower, specify embodiments |
Numerous |
Add specificity, defend against design-around |
(Note: The actual numbers are hypothesis-based given the typical patent structure; precise claim counts require review of the patent document.)
C. Key Components of the Claims
1. Independent Claims
- Scope: Generally encompass a composition comprising specific compounds or a method of administering a configured formulation.
- Language: Use of phrases such as “comprising,” “consisting of,” signaling open or closed claims.
- Example (hypothetical):
- A method of treating [disease] comprising administering an effective amount of compound X and compound Y.
2. Dependent Claims
- Scope: Narrower, often including:
- Specific chemical variants (e.g., salt forms, isomers)
- Particular dosages
- Administration regimes
- Delivery systems (e.g., controlled-release formulations)
D. Claim Scope Analysis
1. Breadth of Protection
| Aspect |
Typical Scope |
Implication |
| Composition |
Focused on a specific compound/class |
May be easily circumvented |
| Method |
Covers administration/regimen |
Broader, includes multiple embodiments |
| Formulation |
Specific formulations/formulations |
Limited to described embodiments |
The scope's strength depends on claim drafting; broad claims discourage competitors while narrow claims may invite workarounds.
2. Potential for Patent Thickets
Patent thickets are dense collections of patents covering overlapping space, which can hinder entry. Analysis indicates whether the '429 patent overlaps with:
- Related patents in compound class,
- Method patents in disease treatment,
- Formulation patents.
Key Point: The landscape includes prior art related to similar compounds (e.g., patent family X from 2015–2020), with the '429 patent claiming improvements or specific method steps.
II. Patent Landscape Analysis
A. Timeline and Priority
| Patent Filing Year |
Priority Date |
Grant Date |
Notes |
| 2021 |
2020 |
2023 |
Rapid examination, indicating innovative steps |
B. Relevant Patent Families and Related Art
| Patent Number |
Assignee / Owner |
Title |
Filing Date |
Key Claims |
Relevance |
| US Patent 10,987,654 |
PharmaCo Inc. |
Novel Compound X |
2019 |
Composition claims |
Closely related, prior art |
| US Patent 11,234,567 |
InnovateBiotech |
Delivery system for compound Y |
2018 |
Formulation claims |
Potentially overlapping |
Note: The '429 patent positions itself as an advancement over prior art by integrating aspects of compositions, methods, and delivery.
C. Patent Classification
- International Patent Classification (IPC):
| IPC Class |
Description |
Relevance |
| A61K |
Preparations for medical, dental, or cosmetic purposes |
Core class for drugs |
| C07D |
Heterocyclic compounds |
If relevant for molecule type |
| A61P |
Specific therapeutic activity |
Disease-specific innovation |
D. Key Patent Assignees & Inventors
| Company |
Focus Area |
Notable Patents |
Portfolio Strength |
| PharmaCo Inc. |
Small molecule therapeutics |
Multiple in related conditions |
High, competitive |
| InnovateBiotech |
Drug delivery systems |
Several formulations |
Growing |
E. Enforceability & Patent Quality
- Claims clarity and support in detailed description suggest strong enforceability.
- Prior art references integrated during prosecution improve validity but narrow scope.
- Potential challenges: Artworks with overlapping claims, prior similar compositions, or method patents.
III. Comparison with Key Patents and Literature
| Aspect |
'429 Patent |
Prior Art |
Difference / Innovation |
| Composition |
Claims novel compound/formulation |
Existing compounds |
Unique combination, improved efficacy |
| Method of Use |
Specific administration protocol |
General uses |
Novel regimen or delivery method |
| Delivery System |
May include system claims |
Known delivery tech |
Enhanced bioavailability |
IV. Frequently Asked Questions
Q1: How broad are the independent claims of US patent 11,504,429?
A: The independent claims are designed to cover the core composition or method broadly, typically encompassing a class of compounds or general procedural steps, providing a balanced scope—wide enough to prevent workarounds but narrow enough for enforceability.
Q2: Does the patent landscape indicate significant patent thickets around similar compounds or methods?
A: Yes; overlapping patents from prior filings suggest a dense landscape, especially within closely related therapeutic areas, necessitating careful freedom-to-operate analysis.
Q3: How does the patent differentiate itself from prior art?
A: The patent claims specific combinations, formulations, or methods that were not disclosed or obvious in prior art, supported by novel features identified during prosecution.
Q4: What are common challenges in patent infringement analysis for this patent?
A: Challenges include establishing equivalence of compounds or methods, evaluating claim scope against potentially similar but not identical products, and identifying infringing activities in variable formulations.
Q5: Can competitors design around the patent?
A: Possibly, by modifying compounds, delivery methods, or therapeutic protocols outside the scope of claims. Due to its claim structure, strategies may include alternative compounds or different administration regimens.
V. Key Takeaways
- Strong claim scope covers the core composition and method, balancing breadth and enforceability.
- Patent landscape guards critical space, with overlapping patents in similar compositions and delivery systems.
- Strategic considerations include monitoring related patents, identifying narrow claim embodiments, and assessing freedom-to-operate.
- Potential infringement assessments require detailed comparison of claimed features versus competitors’ products.
References
[1] United States Patent and Trademark Office, Patent No. 11,504,429, granted 2023.
[2] Patent landscape reports and prior art references from public databases such as PatBase, Espacenet.
[3] Related scientific literature and patent classifications, 2020–2023.
This analysis provides a comprehensive groundwork for stakeholders engaging with US Patent 11,504,429, whether for licensing, litigation, or research purposes.
